These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 17617377)
21. Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Xu J; Wu Y; Song P; Zhang M; Wang S; Zou MH Circulation; 2007 Aug; 116(8):944-53. PubMed ID: 17679617 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner. Hernández-Vargas H; von Kobbe C; Sánchez-Estévez C; Julián-Tendero M; Palacios J; Moreno-Bueno G Cell Cycle; 2007 Nov; 6(21):2662-8. PubMed ID: 17912036 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II. Dennis AP; Lonard DM; Nawaz Z; O'Malley BW J Steroid Biochem Mol Biol; 2005 Mar; 94(4):337-46. PubMed ID: 15857753 [TBL] [Abstract][Full Text] [Related]
24. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells. Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039 [TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer. Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864 [TBL] [Abstract][Full Text] [Related]
26. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors. Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833 [TBL] [Abstract][Full Text] [Related]
27. RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells. Mao H; Zhang L; Yang Y; Sun J; Deng B; Feng J; Shao Q; Feng A; Song B; Qu X Gene; 2011 Oct; 486(1-2):74-80. PubMed ID: 21801820 [TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645 [TBL] [Abstract][Full Text] [Related]
29. The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism. Pajonk F; van Ophoven A; Weissenberger C; McBride WH BMC Cancer; 2005 Jul; 5():76. PubMed ID: 16001975 [TBL] [Abstract][Full Text] [Related]
30. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells. Choi YH Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742 [TBL] [Abstract][Full Text] [Related]
31. Genetic analysis of the DBC2 gene in gastric cancer. Cho YG; Choi BJ; Kim CJ; Song JH; Zhang C; Nam SW; Lee JY; Park WS Acta Oncol; 2008; 47(3):366-71. PubMed ID: 17906984 [TBL] [Abstract][Full Text] [Related]
32. Mutation analysis of the DBC2 gene in sporadic and familial breast cancer. Ohadi M; Totonchi M; Maguire P; Lindblom A; Habibi R; Alavi BA; Keyhani E; Najmabadi H Acta Oncol; 2007; 46(6):770-2. PubMed ID: 17653899 [TBL] [Abstract][Full Text] [Related]
33. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. Desai SD; Li TK; Rodriguez-Bauman A; Rubin EH; Liu LF Cancer Res; 2001 Aug; 61(15):5926-32. PubMed ID: 11479235 [TBL] [Abstract][Full Text] [Related]
34. Reactive oxygen species regulate nucleostemin oligomerization and protein degradation. Huang M; Whang P; Chodaparambil JV; Pollyea DA; Kusler B; Xu L; Felsher DW; Mitchell BS J Biol Chem; 2011 Apr; 286(13):11035-46. PubMed ID: 21242306 [TBL] [Abstract][Full Text] [Related]
35. Inducible p27(Kip1) expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors. Drexler HC; Pebler S Cell Death Differ; 2003 Mar; 10(3):290-301. PubMed ID: 12700629 [TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of a Drosophila proteasome regulatory network. Lundgren J; Masson P; Mirzaei Z; Young P Mol Cell Biol; 2005 Jun; 25(11):4662-75. PubMed ID: 15899868 [TBL] [Abstract][Full Text] [Related]
37. Induction and attenuation of neuronal apoptosis by proteasome inhibitors in murine cortical cell cultures. Suh J; Lee YA; Gwag BJ J Neurochem; 2005 Nov; 95(3):684-94. PubMed ID: 16144541 [TBL] [Abstract][Full Text] [Related]
38. p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. MacLaren AP; Chapman RS; Wyllie AH; Watson CJ Cell Death Differ; 2001 Mar; 8(3):210-8. PubMed ID: 11319603 [TBL] [Abstract][Full Text] [Related]
39. Loss of DBC2 expression is an early and progressive event in the development of lung adenocarcinoma. Dong W; Meng L; Shen HC; Du JJ Asian Pac J Cancer Prev; 2012; 13(5):2021-3. PubMed ID: 22901165 [TBL] [Abstract][Full Text] [Related]
40. [Mechanism of G2/M cell cycle arrest before apoptosis in leukemia cell line HL-60 induced by proteasome inhibitor MG132]. Sun GJ; Qian JJ; Meng XB; Song Y; Zhang F; Mei ZZ; Dong Y; Sun ZX Ai Zheng; 2004 Oct; 23(10):1144-8. PubMed ID: 15473924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]